What Happened?
Shares of healthcare services company Agilon Health (NYSE: AGL) fell 13.5% in the afternoon session after a disappointing February jobs report revealed an unexpected contraction in employment, with significant job losses in the healthcare sector.
The U.S. economy lost 92,000 nonfarm payroll jobs, a sharp reversal from the 50,000 gain that economists had anticipated. The healthcare industry, typically a source of job growth, shed 28,000 positions. This was a stark contrast to its strong gains in the previous month. The discouraging data raised investor concerns about a potential economic slowdown, which could lead to reduced healthcare spending and demand for services. The Labor Department noted that the drop in healthcare hiring was partly due to recent strike activity.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy agilon health? Access our full analysis report here, it’s free.
What Is The Market Telling Us
agilon health’s shares are extremely volatile and have had 81 moves greater than 5% over the last year. But moves this big are rare even for agilon health and indicate this news significantly impacted the market’s perception of the business.
The previous big move we wrote about was 2 days ago when the stock gained 23.1% on the news that its Chief Markets Officer, Benjamin Shaker, purchased 500,000 shares of common stock. The transaction was valued at approximately $301,050 and increased Shaker's holdings by about 57.6% to a total of 1,367,674 shares. A significant stock purchase by a high-ranking executive was viewed by investors as a strong signal of confidence in the company's future prospects. The market reacted positively because this kind of insider buying suggested that leadership believed the stock was undervalued.
agilon health is down 12.6% since the beginning of the year, and at $0.59 per share, it is trading 89.6% below its 52-week high of $5.68 from April 2025. Investors who bought $1,000 worth of agilon health’s shares at the IPO in April 2021 would now be looking at an investment worth $19.00.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
